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ABSTRACT 
Two new ribosome-inactivating proteins (Rffs), designated 5- and s-
momorcharin (6- and s-MMC), were isolated from the seeds and fruits of 
Momordica charantia, respectively. The method for the isolation of a- and P_ 
momorcharin (a- and P-MMC) was adopted for the isolation of these two new 
REPs. Li this method, an affinity column of Affi-Gel Blue gel was used to remove 
most of the non-RP like proteins from the crude extract. A fast protein liquid 
chromatography (FPLC) column, Mono S, was used to resolve proteins adsorbed 
on the affinity column. 
6- and s-MMC were shown to possess molecular weights of 30 kDa and 24 
kDa, respectively. They were also shown to have A^-glycosidase activity, which is 
characteristic of other Rffs. Like other Rffs, 5-MMC was highly potent in 
inhibiting cell-free translation in rabbit reticulocyte lysate with a 50 % inhibitory 
concentration (IC50) at 0.15 nM. On the other hand, s-MMC was much less 
potent. Its IC50 was shown to be 0.17 |iM. 
The yields of 5- and s-MMC were low. From 5 g of seeds, 34 i^g of 5-MMC 
were isolated. From 500 g of fruits, 62 p,g of s-MMC were isolated. The reason 
for the low content of these two Rffs in their tissues is unknown. Further research 
is required. 
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LIST OF ABBREVLVTIONS 
APA : Abrus precatorius agglutinin 
a-MMC : alpha-momorcharin 
P-MMC : beta-momorcharin 
ConA : Concanavalin A 
DEPC : Diethyl pryocarbonate 
DNase : Deoxyribonuclease 
DTH : Delayed-type hypersensitivity 
EP : Electrophoresis buffer 
FPLC : Fast protein liquid chromatography 
y-MMC : Gamma-momorcharin 
HTV : Human immunodeficiency virus 
kb : Kilobase 
kDa : Kilodalton 
LPS : Lipopolysaccharide 
IC50 : 50 % inhibitory concentration 
IT : Lnmunotoxin 
MAP30 : Momordica anti-HTV protein 30 
MWCO : Molecular weight cut-off 
NAD : Nicotinamide adenine dinucleotide 
NK : Natural killer 
PHA : Phytohaemagglutinin 
PVDF : Polyvinylidene difluoride 
Rff : Ribosome-inactivating protein 
RCA : Ricinus communis agglutinin 
RNase : Ribonuclease 
SDS-PAGE : Sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
sRn> : Small RH> 
SV : Simian virus 
TCS : Trichosanthin 
TEMED : N’ N, N, iV-tetramethyl ethylene diamine 
VAA : Viscum album agglutinin 
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1.1 Ribosome-inactivating proteins ^RIPs) 
1.1.1 Classification ofRIPs 
Ribosome-inactivating proteins (RBPs) are a group of toxic proteins 
widely distributed in plants and they inhibit protein translation inside cells. 
RJPs are classified into four types, namely, type I，type H, type TV and a 
novel type called small RJPs. Type I RJPs are single-chain proteins with a 
molecular weight of around 30 kDa. They are the most abundant type among the 
four types (Table 1.1 and 1.2). Type H RPs are double-chain proteins which 
contain an active A chain and a cell-binding B chain linked together through 
disulphide linkage or hydrophobic interactions (Fig. 1.1). The A chain is similar 
to the type I PJPs and possesses the activities of RJPs. Its molecular weight is 
between 26 - 32 kDa. The B chain is a glycosylated protein with a molecular 
weight of around 34 kDa. It is a lectin which enables it to bind to galactosyl-
terminated receptors on the cell surface. As a result, the active A chain can enter 
cells much more easily than type I RCPs and so type H RJPs are more toxic than 
type I RJOPs. 
There are some relatively non-toxic type H RJDPs. Ebulin 1 (Girbes et al., 
1993b) and nigrin b (Girbes et al., 1993a) have toxicity at nanomolar levels, as 
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high as that of other type H RJDPs on cell-free translation system. But, they are 
relatively non-toxic towards intact cells in comparison with other type E RJDPs. 
This led to further classification into toxic and non-toxic type E RPs (Citores et 
aL, 1993) (Table 1.3). 
Table 1.1 Families and species of plants with type I RIPs and some 
examples ofthe purified type I RJPs QBarbieri et aL^ 1993). 
Family Genus and species Name ofRJP 
Asparagaceae Asparagus officinalis asparin 1 
asparin2 
Caryophyllaceae Agrostemma githago agrostin2 
agrostin 5 
agrostin 6 
Dianthus barbatus dianthin 29 
Dianthus caryophyllus dianthin 30 
dianthin 32 
Lychnis chalcedonica lychnin 
Petrocoptis glaucifolia petroglaucin 









Cucurbitaceae Bryonia dioica bryodin-L 
bryodin-R 
Citrullus colocynthis colocin 1 
colocin 2 
Cucumis melo melonin 
Luffa acutangula luffaculin 
Luffa cylindrica luffin a 
luffmb  
(to be continued on p.4) 
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Table 1.1 (continued)  
Family genus and species Name ofREP  
Cucurbitaceae Momordica charantia a-momorchain 
P-momorchain 
Momordica cochinchinensis momorcochin-S 





Trichosanthes cucumeroides p-trichosanthin 
Euphorbiaceae Croton tiglium crotin 
Gelonium multiflorum gelonin 
Hura crepitans Hura crepitans RBP 
Jatropha curcas curcin 2 
Manihot palmata mapalmin 
Manihot utilissima manutin 1 
manutin 2 
Nyctaginaceae Mirabilis jalapa MAP 
Phytolaccaceae Phytolacca americana PAP 
Phytolacca dioica PD-S1 
PD-S2 
PD-S3 
Phytolacca dodecandra dodecandrin 
dodecandrin-C 
Poaceae Hordeum vulgare barley Rff 
Secale cereale Secale cereale R P 
Triticum aestivum tritin  
\Zea mays |maize R P  
Table 1.2 Families and species of plant with type H REPs and some 
examples of purified type n RJPs CBarbieri et al” 1993). 
Family Genus and species Name ofRJP 
Euphorbiaceae Ricinus communis ricin 
Ricinus agglutinin 
Fabaceae Abrus precatorius abrin 
PassifIoraceae Adenia digitata modeccin 
Adenia volkensii voUcensin 
Sambucaceae Sambucus ebulus ebulin 1 
Viscaceae Phoradendron californicum P. californ. lectin  
Viscum album viscumin  
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T y p e i m P TypeHRff / H 
A chain B chain 
Rg. 1.1 Structures oftype I and type H REPs. 
Type rV REPs are tetrameric. They resemble type E RBPs but each type IV 
REP has two A chains and two B chains. The molecular weights ofA chain and B 
chain are around 32 kDa and 34 kDa, respectively. Type IV RPs are agglutinins. 
They can also be classified into toxic and non-toxic ones (Citores et al., 1993) 
(Table 1.3). Ricinus communis agglutinins (RCA), Abrus precatorius agglutinins 
(APA) and Viscum album agglutinins fVAA) are examples oftype W RJCPs. 
Table 1.3 Classification o f R g s .  
Type Sub-classes Examples References 
I normal Asparin 1，Agrostin 2，a- (Barbieri et al., 1993) 
momorcharin, Crotin 
H toxic Ricin, abrin (Barbieri et al., 1993) 
non-toxic Ebulin 1，nigrin b (Girbes et al., 1993a; 
Girbes et al., 1993b) 
IV toxic Ricinus communis agglutinin (Citores et al., 1993) 
(RCA), Abrus precatorius 
agglutinin (APA) 
non-toxic Viscum album agglutinin (VAA) (Citores et al., 1993) 
Small RIP toxic LufBn S, g-MMC (Gao et al., 1994； Pu et  
al., 1996)， ， 
Recently, there are some single-chain Rffs found to have a molecular 
weight of around 10 kDa. They are classified as small RJCPs (sRff). Luffm S from 
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Luffa cylindrica (Gao et al., 1994) and g-momorcharin from Momordica charantia 
(Zheng et al., 1996) are examples of sREP. 
1.1.2 Distribution ofRIPs 
iUPs are widely distributed in the plant kingdom. It is found in both 
dicotyledonae and monocotyledonae of Angiospermae. It has not yet been found 
in Gymnosperaiae. Type I RJDPs are much more abundant than type H REPs (Table 
1.1). Type n Rffs can only be found in five families (Table 1.2). 
Li a single plant speices, it is possible that more than one form of Rff 
exist. Examples are the RPs found in Phytolacca americana (pokeweed) OBarbieri 
et al., 1982; Lrvin，1975; L:vin et al., 1980)，Bryonia dioica (bryony) 03arbieri et 
al., 1989; Gasperi-Campani et al., 1980; Stirpe et al., 1986) and Saponaria 
officinalis (Ferreras et al., 1993)，which produce many different isoforms of type I 
Rffs. 
Many RJDPs found so far are located in the seeds fBarbieri et al., 1993). 
They can also be found at various parts of a plant, even at the latex (Stirpe et al., 
1983). The different forms ofRJPs from Phytolacca americana, Bryonia dioica 
and Saponaria officinalis mentioned above are found in the seeds, roots and 
leaves of the plants OBarbieri et al., 1982; Barbieri et al., 1989; Ferreras et al., 
1993; Gasperi-Campani et aL, 1980; L:vin, 1975; Lrvin et aL, 1980; Stirpe et al., 
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1986). The type H Rffs modeccin and voUcensin can be found in roots and seeds 
(Gasperi-Campani etal” 1978; Stirpe etal., 1985). 
RPs are not only found in higher plants. They are also found in bacteria. 
Shiga toxin was purified from Shigella dysenteriae type I. Shiga-like toxin I 
(SLT-I) and Shiga-like toxin H (SLT-E) were purified from enterohaemonphagic 
Escherichia coli. These baterial toxins have the same enzymatic properties of 
type I RDPs (Strockbine et aL, 1986). 
]n fungi, Aspergillus giganteus produces the toxin a-sarcin with specific 
RNase activity on the 28S rRNA ^)ndo and Wool, 1982). Aspergillus restrictus 
produces restrictocin and mitogillin (Fando et al., 1985). a-Sarcin, restrictocin 
and mitogillin cleave the phosphodiester bond between G4325 and A4326. It is 
very near the site of action of conventional RJDPs on the eukaryotic ribosome. 
Their effect on cells also involves protein synthesis inhibition. 
1.1.3 Molecular biology ofRIPs 
The majority of the mRNA sequences ofRffs code for iV-terminal and C-
terminal peptides which are post-translationally cleaved to form the mature RJP 
CFig 1.2). Most of the REP genes contain no introns in their genomic sequences. 
One exception is the gene ofMAP from M jalapa (Kataoka et al., 1993). Maize 
b-32 R P has an internal sequence in the nascent polypeptide This internal 
sequence is cleaved to form the mature protein (Fig 1.2). The TV-terminal signal 
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sequences are hydrophobic which resemble the signal sequences of other 
eukaryotic and prokaryotic proteins (Kataoka et aL, 1991). 
Leader C-terminal 
^ Mature peptide ~^^^ 
Dianthin30 23 252 18 
Saporin-S6 24 253 22 
MAP 28 250 --
Leader Unker C-terminal 
| j j ^ ^peptide ^ j j p-peptide J ^ ^ 
Maize RIP 16 141 25 71 44 
Leader Unker 
m m i A chain j J j | | B chain 
Ricin D 24 267 12 262 
Ricinu3 agglutinin 24 266 12 262 
Abrin 34 241 14 276 
Fig. 1.2 Structures of prepro-forms of some type I and H RBPs. 
MAP=Mirabilis antiviral proteins. Maize REP is a type I RCP; but unlike 
other type I MPs, it is synthesied with the a- and P-peptides linked by a 
Unker sequence. Leader sequence, linker and C-terminal are absent in 
mature REPs. The number of amino acids in each peptide chain is indicated. 
The feature of the iV-teraiinal signal sequence enables the biosynthesis of 
RJPs to be compatible with their enzymatic activity. It is because the prepro-forai 
of RJDPs may be inactive so that it would not damage its own ribosomes. This N-
terminal sequence can direct the prepro-form to the endoplasmic reticulum OER). 
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The terminal sequences can be cleaved to form the active protein only at the ER. 
Other features, such as insensitivity to homologous ribosome may also contribute 
to the compatibility of toxicity to biosynthesis. 
The biosynthesis of ricin and Ricinus communis agglutinin (RCA) is well 
elucidated OHarley and Lord, 1985; Lord, 1985a; Lord, 1985b; Roberts and Lord, 
1981). The A^-terminal signal sequences of the prepro-forms direct the proteins to 
the endoplasmic reticulum. Then, the signal sequences are removed to form the 
pro-form. Glycosylation and di-sulphide bond formation occur at the ER as well. 
The proteins are then transported by Golgi apparatus and Golgi vesicles to the 
protein bodies. Then, an acid proteinase processes the pro-form to form the 
mature RJPs. 
1.1.4 Physical and chemical properties ofRIPs 
The molecular weights of type I REPs are around 30 kDa (Table 1.4). The 
A chains of type H Rffs also have similar molecular weights as type I Rffs and 
the B chains are about 34 kDa in molecular weight (Table 1.5). 
The majority of the REPs found so far are glycosylated. But there are some 
notable exceptions. For example, trichosanthin and abrin A chain are non-
glycosylated. The percentage of glycosylation is different for different Rffs 
(Tables 1.4 & 1.5). The sugars in Rffs are glucose, galactose, mannose, fucose, 
xylose and A^-acetyl-D-glucosamine (Barbieri et al., 1993). 
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Table 1.4 Molecular weights of some type 1 RIPs ^Barbieri et al； 
1993) 
RIPs Molecular Weight (kDa) Glycosylarion (%) 
Agrostin 5 29.5 6.87 
Asparin 1 30.5 * 
Barley RIP 30.0 ** 
Bryodin (from root) 30.0 6.3 
Colocin 2 26.3 1.59 
Crotin 2 30.2 0.41 
Curcin 2 28.1 糾 
Dianthin 30 29.5 1.56 
Dodecandrin 29.0 0 
Gelonin 30.0 ** 
Hura crepitans RIP 27.5 0.94 
LuffacuIin 28.0 * 
Luffm a 28.2 0 
Maize RIP 25.0 0 
Mapalmin 32.3 5.99 
MAP 27.8 0 
Momorcochin-S 30.7 2.82 
a-Momorcharin 29.1 1.74 
PAP 29.0 0 
PD-S2 32.0 2.22 
Saporin-S6 29.5 0 
Trichokirin 27.0 1.27 
Trichosanthin 26.0 0 
Tritin ^ ^  
* Glycosylation exists but amount is unknown 
** Glycosylation is unknown 
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Table 1.5 Molecular weight & glycosylation of some type H RBPs 
flBarbierigM/.，1993) 
Type II RIPs Molecular weight (kDa) Glycosylation (%) 
Abrin c 63.8 7.4 
A chain 30.0 0 
B chain 36.0 7.4 
Ebulin 1 56.0 ** 
A chain 26.0 ** 
B chain 30.0 ** 
Modeccin 60.0 2.7 
A chain 27.8 * 
B chain 31.0 * 
Ricin D 63.0 * 
A chain 30.0 4.5 
B chain 33.0 * 
Viscumin 60.0 11.8 
A chain 29.0 * 
B chain 32.0 * 
Volkensin 62.0 5.7 
A chain 29.0 * 
B chain 36^ * 
* Glycosylation exists but amount is unknown 
** Glycosylation is unknown 
Glycosylation of the type I RJPs and A chains of type H Rffs may be non-
essential to the activity. It is because the type and percentage of glycosylation 
vary from one R P to another. Rffs such as trichosanthin and abrin A are non-
glycosylated. When gelonin and ricin A chain are partially deglycosylated, their 
activities are not affected (Barbieri et aL, 1993). More striking is that when 
recombinant ricin A chain is produced in E. coli and is not glycosylated, it is still 
fully fimctional (Barbieri et al” 1993). 
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Type I REPs are invariably basic proteins. Their pI values are higher than 
7. Usually, their pI values are equal to or higher than 9 (Gelfi et al., 1987). The pI 
values of the A chains of type H and type W RBPs range from 4.6 to 8.6 (Barbieri 
etal； 1993). 
1.1.5 Enzymatic and translation-inhibitory activities 
The characteristic property of RBPs is their A^-glycosidase activity. It was 
elucidated by Endo and colleagues in 1986 OEndo et al., 1990). RTPs attack the 
28S rRNA. As the rRNA is located at the junction between the 60S and 40S 
subunit which interacts with elongation factors EF2 and the mRNA for successful 
translation, destruction of rRNA by REPs would result in failure of translation. 
Rff target a-sarcin target 
C G ^ V I G / A G 
�… / 
...ribose - p - ribose - p - rioose - p - ribose - p ^ b o s e - p - ribose ... •.....•..••...•. < . . • . . . • . . • . . . . • • • • • • A G . . - - - " U G G A A A C C U C C—G G _ C G _ C C _ G U C—G A _ U 
4308 A _ U 4339 
Rat 28S rRNA 
Fig. 1.3 The site of cleavage by the A^-glycosidase activity ofRIPs (Stirpe 
etal” 1992). 
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Li the 28S rRNA, there is a highly conserved stem and loop structure. 
REPs specifically depurinate the A4324 on the rat liver ribosome (Fig. 1.3). The 
cleavage leads to the failure of GTP-dependent binding ofEF-2, EF-2-dependent 
hydrolysis ofGTP and binding ofEF-l. As a result, protein synthesis is inhibited. 
The activity is very potent. It inhibits the ribosome at nanomolar concentrations 
(Table 1.6). 
The mechanism of RJPs' iV-glycosidase activity was proposed by 
Monzingo and Robertus (1992) (Fig. 1.4). This mechanism was applied to ricin A 
chain. But this may also be applied to other iUPs ^VIonzingo and Robertus, 1992). 
Ln this mechanism, there is oxycarbonium ion formation. There are two 
variations. Li the first one ^Fig. 1.4), the target adenosine is stacked between two 
aromatic side chains tyrosine 80 and 123 (not shown). Arginine 180 protonates 
the adenine to form an oxycarbonium ion which is stabilized by the negatively 
charged glutamate 177 and the hydrogen bonding from glycine 121 and valine 81. 
After protonation, the arginine 180 attacks a nearby water molecule. The 
activated water molecule attacks the oxycarbonium ion and releases the adenine 
leaving group. Another proposed mechanism is similar. But, the water molecule 
is attacked by the hydrogen-bonded oxycarbonium structure instead of the arginine 
180 in the first mechanism. The final structure is that the N9 becomes covalently 
bound to a hydrogen instead of the N3. 
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Fig. 1.4 The proposed mechanism of N-gIycosidase activity of RBPs 
OMonzingo and Robertus, 1992). The top mechanism has N3 being 
protonated. The low mechanism has N9 being protonated. Please refer 
to the text for details. 
As a consequence ofthe 7V-glycosidase activity, RJDPs inhibit the translation 
in cell-free and whole cell systems (Barbieri et al., 1993). The values of 50 % 
inhibitory concentration fECso) of some REPs on the translation of rabbit 
reticulocyte lysate and HeLa cells are shown in Table 1.6. Their IC50 values are 
as low as at 0.06 nM in the cell-free system. 
Apart from eukaryotic ribosomes, REPs can also inhibit prokaryotic 
ribosomes. Bacterial ribosomes, like those from E. coli, are very sensitive to type 
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I REPs (Habuka et al., 1990). As a result, expression of type I RJCPs in E. coli is 
often limited. But, on the contrary, ricin, a type H RJP, does not depurinate the E. 
coli ribosome (Cammarano et al., 1985) and so, it can be expressed in E. coli. 
Table 1.6 The inhibitory effect of some RBPs on protein synthesis in a ceU-free 
system (rabbit reticulocyte lysate) and a whole cell system CHeLa ceUs) and their 
toxicity to mice QBarbieri et al； 1993),   
RBPs Cell-Free IC^Q Whole cells Mouse LD50  
^ IC50 (nM) (mgAcg)*  
TypeI 
Agrostin 5 0.47 9200 1.0 
Asparin 1 0.27 >3300 20 
Bryodin-L 0.09 >3300 >10 
Colocin 1 0.04 >3300”* 10.7 
Crotin 2 0.48 >3300 ND 
Curcin 2 0.19 >3300 ND 
GeIonin 0.4 >3300 40 
Hura crepitans REP 0.1 2000 ND 
Lychnin 0.17 >3300 9.3 
Manutin 1 0.03 210 ND 
Mapalmin 0.05 >3300 >8.0 
a-momorcharin 0.06 >3300 7.4 
PAP 0.07 3400 0.95 
PD 0.06 1620 1.12 
Saporin S6 0.037 610-2340 ^  
Type n 
Abrin 88 0.0039 0.00056 
A chain 0.5 >0.4 
Ricin 84 0.0011 0.0026 
A chain 0.1 >0.4 
Modeccin 45 0.0003 0.0023 
A chain 2.3 
Viscumin 43.3 0.008 0.0024 
A chain 3.5 
Volkensin 84 0.0123 0.00138 
A chain 0 ^  
*LD50 = 50 0/0 lethal dose to mice; ND = not determined. 
The frnigal ribosomes are generally sensitive to Rffs fBradley et al., 1987). 
Ribosomes of fungi like S. cerevisiae and N. crassa can be inhibited by RPs with 
high efficiency (Bradley et aL, 1987). 
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Although many Rffs are inactive towards their own (autologous) 
ribosomes, it was shown that they can be active on autologous ribosomes at high 
concentrations O^restle etal” 1992). 
t i short, the activity of REPs on different types of ribosomes are varied. 
More research will be needed for the complete elucidation of the basis for the 
differences. 
Some RJDPs were found to possess DNase (Go et al., 1992) and RNase 
(Mock et al., 1996) activities. Those activities will be discussed in detail in 
section 1.2.2. 
1.1.6 RIP-based Immunotoxins 
As RJDPs are effective in killing cells, they can be used to specifically target 
to undesired or harmful cells. As a result, a large number of immunotoxins (JTs) 
in which RJCPs conjugated with antibodies were constructed and examined for 
different kinetics and pharmacological studies (Ramakrishnan et al., 1992). 
Rn^-containing ITs were used in many in vitro studies, mainly for anti-
tumour study (Ramakrishnan et al., 1992). Li an in vivo local treatment in mice, it 
was found that the ricin-containing ITs can effectively control the thymoma grafts 
and human tumour xenografts (Kanellos et al., 1989). In an in vivo human 
treatment, an IT of saporin-S6-containing anti-CD30 monoclonal antibody was 
used to treat Hodgkin's lymphoma (Falini et al., 1992). 
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The studies of TTs containing Rffs have been mostly in vitro or animal 
model studies (Barbieri et al., 1993). However, as more data will be obtained 
there will be more clinical trials for the different therapies using Rff-containing 
ITs. 
1.2 Momordica charantia and its ribosome-inactivating proteins 
ORIP) 
1.2.1 Momordica charantia 
Momordica charantia Linn is a climbing herbaceous annual. The fruits of 
M charantia are called bitter gourds. They are a favorite dish of Southem 
Chinese. The various parts of M charantia are used as traditional medicine and 
regarded as having the effect of eye-brightening, heat-dissipation and 
detoxification. They have been used to treat sunstroke, dysentery and eye pains. 
In fact, a wide variety of biological activities were identified from its 
fruits. These included guanylate cyclase inhibition (ClafIin et al., 1978), human 
lymphocytes cytotoxic action (Takemoto et al； 1982), cataractogenesis inhibition 
(Srivastava et aL, 1988)，antilipolytic & lipogenic action Q^ Jg et al., 1987), 
insulinomimetic action (Ng et al., 1987)，hypoglycemic action (Ali et al, 1993)， 
tumour growth inhibition (Fletcher et al； 1980) and lectin-like action (Barbieri et 
al., 1987). 
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1.2.2 Ribosome-inactivating proteins ORIPs) in Momordica charantia 
Like many other plants, M. charantia has RJDPs. There are four RJPs 
existing in M. charantia, namely, a-momorcharin (a-MMC), p-momorcharin (P_ 
MMC) C^eung et al.，1988)，y-momorcharin (y-MMC) (Pu et al； 1996) and 
Momordica anti-HTV proteins 30 (MAP30) OLee-Huang et al” 1990). Their 
physical, chemical and biological activities were well characterized. 
Classification and distribution 
There are two classes ofRIPs in M. charantia. They are respectively type I 
and small REPs. a-MMC, p-MMC and MAP30 are type I RJDPs. The thirty in 
MAP30 means 30 kDa. yMMC belongs to the novel class of small RPs. Up to 
now, the existence of type E and type YV RCPs in M. charantia has not been 
reported. 
a-MMC, p-MMC and MAP30 are type I RPs. y-MMC belongs to the 
novel class of small REPs. There is no report of the existence of type E or type W 
RBPs in M charantia. All these four REPs have been isolated from the seeds of M. 
charantia. But MAP30 can also be isolated from the fruits. At present, there is 
no report of isolation ofRBPs from other parts of the plant. 
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Physical and chemical properties 
The physical and chemical properties of FJDPs from M charantia were 
shown in Table 1.7. Like other type I RPs, the molecular weights of a-MMC, P_ 
MMC and MAP30 are around 30 kDa. y-MMC, being a small RH ,^ has a 
molecular weight of 11.5 kDa. a-, P_ and y-MMC are glycosylated while the 
extent of glycosylation ofMAP30 is unknown. 
a- and p-MMC are basic proteins. Their pI values are above 7. This is 
consistent with other type I RIPs which are also basic proteins. y-MMC is also 
basic. The pI value ofMAP30 is unknown. 
Table 1.7. Comparison ofRBPs from Momordica charantia ^^ee-Huang et al” 
1990; Pu et al., 1996; Yeung et aL，1987). 
M. charantia REP j oc-MMC*�丨 g-MMC*� 丨 [ M M C *�丨 MAP30 
. i i S i ) i ^ S ^ ; i ^ ^ 3 j 29 [ 28 1•••.ii"5..………j 30  
Number ofamino acids 263 248� 丨 Unknown�丨 263 
Neutral sugar content (%) | 1.6 | 1.3 | 0 j Unknown 
pI value j 8.5-9.0 j 8.5-9.0 j 9.5 j Unknown 
Homology with a-MMC (%) | 100 | 54 | Unknown | 48  
*: a-, p- & y-MMC = a-，p- & Y_momorcharin, respectively; MAP30 = 
Momordica anti-HTV protein 30. 
ln. considering the homology of these Rffs, they are fairly similar to each 
other. P-MMC and MAP30 have about 50 % homology with a-MMC. There are 
no studies on the homology of y-MMC with other available M. charantia Rffs. 
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Biological activities 
Like RJPs from other plants, RJDPs from M. charantia has the characteristic 
A^-glycosidase activity (Fong et al., 1996; Lee-Huang et al., 1995a; Pu et aL, 
1996). They depurinate specifically the 28 S rRNA in the large subunit of the 
eukaryotic ribosome. They also inhibit translation in cell-free systems QLee-
Huang et al., 1995a; Pu et al., 1996; Yeung et al, 1988). Apart from these 
activities, DNase/RNase activity, abortifacient activity, immunomodulatory 
activity, anti-tumour activity and anti-viral activity can also be observed in some 
of the M charantia RJPs. 
(i) DNase/RNase activities 
a-MMC, p-MMC and MAP30 possess deoxyribonuclease ^)Nase) 
activity, a- and p-MMCs also have RNase activity. 
When a- and P-MMC were incubated with supercoiled, double-stranded 
SV-40 DNA from monkey, nicked circular and linear DNAs were produced (Go et 
al., 1992). On the other hand, when MAP30 was incubated with the DNA of 
human immunodeficiency virus (HTV), the predominant supercoiled DNA was 
converted to the relaxed form, even in the presence of gyrase which would have 
converted the relaxed form back to supercoiled form (Lee-Huang et al., 1995a). 
As a- and P-MMC were active towards another supercoiled DNA ofM13 
mpl8 and they were inactive towards linear DNAs such as lambda, Ad-2 and T7, 
it was suggested they recognized the conformation of supercoiled DNA substrate 
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(Go et al., 1992). The DNase property may be the mechanism for the anti-viral 
activity of these RPs as will be discussed below. 
On the other hand, a- and P-MMC have RNase activity (Mock et al； 
1996). They were also effective towards tRNA and polyU (Mock et al., 1996). 
The significance of this activity is not known. 
(ii) abortifacient activity 
Another activity that can be found among the Rffs from M. charantia is 
abortifacient activity. This activity exists in a- and P>MMC. There are no 
reports on the abortifacient effect ofMAP30 or y-MMC. 
It was the abortion-inducing effect of M charantia fruit extract that led 
Yeung et al. (1986) to study the seeds of this plant and isolate a- and P-MMC. 
When the two MMCs were administered into mice in mid-term pregnancy, they 
induced 100 % abortion at the concentration of0.05 mg/25 g body weight (Yeung 
et al., 1986). This effect was also observed in early pregnancy but at a higher dose 
O g^ etal., 1992) (Table 1.8). 
The mechanisms of the abortifacient activities ofthe MMCs in early and 
mid-term pregnancy are different. Li early abortion, the development ofembryo is 
affected. The MMCs inhibit the synthesis of macromolecules (RNA, DNA and 
protein) in embryo, leading to degeneration of embryos (Chan et al., 1984). They 
also decrease the number of implantation sites of embryos to the uterus (Chan et 
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a/” 1985). i i mid-term abortion, the trophoblasts in placenta are damaged and 
expelled from the matemal body ^,au, 1983). 
Table 1.8. Early and mid-term abortifadent effect ofa- and P-momorcharin 
in mice flVg et al； 1992; Yeung et aL, 1986). 
R I P s i Dose mg/25 g body j Days pregnant j N o . o f m i c e 1 No. ofaborted mice 
wt. ofmlce when dnig was • j no. oftreated mice  
1 i administrated ‘ j j (%) .b  
a-MMC I 0.05 | 12 | 7 j 7/7(100) 
I 0.20 I 3 I 8 I 5/8 (62.5) 
P-MMC 0.05 12 9 ！ 9/9(100) 
i 0.20 [ 3 [ 10 I 9/10 (90) 
a： day 3 was considered as early pregnancy; day 12 is mid-term pregnancy. 
b: a mouse was considered aborted when dead fetuses were found at over 50 % ofits implantation 
sites; the abortion rate was the percentage of no. ofaborted mice to no. oftotal mice. 
(iii) immunomodulatory activity 
On further study of a- and p-MMC by Leung et al (1987)，it was found 
that these two MMCs possessed a wide variety of immunomodulatory effects. 
a- and p-MMC suppressed the mitogenic response ofsplenocytes towards 
mitogens including concanavalin A (Con A), phytohaemagglutinin OPHA) and 
lipopolysaccharide (LPS) ^.eung et al” 1987). The same research group also 
showed that a- and P-MMC suppressed the delayed-type hypersensitivity ODTH) 
of mice towards sheep red blood cells and that they inhibited the production of 
interleukin-2. Since Con A & PHA are T cell mitogens, DTH is a T cell response 
and interleukin-2 is a T cell-derived lymphokine, it was suggested that a- and P_ 
MMC act on T-cells in the immune system ^.eung et al., 1987). 
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On the other hand, a- and P-MMC affect B cells as well. This is 
supported by the inhibition of the mitogenic effect of LPS by the two MMCs 
(Leung et al., 1987). Meanwhile, a - and p-MMC also suppressed the humoral 
immune response of mice towards sheep red blood cells OLeung et al.’ 1987). 
a- and P-MMC also inhibit the migration as well as the phagocytic and 
cytostatic effects of macrophages (Leung et al., 1987). However, they did not 
affect the cytotoxic effect of natural killer QSfK) cells (Leung et al； 1987). 
The selective suppression of immune cells was not a result of 
lymphocytotoxicity as the viability of the treated cells was not affected ^Leung et 
al” 1986). It was suggested that macromolecule synthesis in the immune cells 
was inhibited as in the embryo 0^¾ et al； 1992). But further studies are required 
before the exact mechanism is elucidated. 
(iv) anti-tumour activtiy 
a- and P-MMC also have anti-tumour effect in vitro. They inhibited 
protein synthesis in a variety of tumour cell lines at concentrations lower than 
micromolar level (Table 1.9). These cell lines included rat hepatoma (H35), 
mouse melanoma (B16), human squamous carcinoma 0-ICRyTO^4 & 
LICR>WJ11), human nasopharyngeal carcinoma QSfPC/HKl) and human 
choriocarcinoma (JAR). a-MMC can also inhibit a sarcoma cell line (S180) at a 
similar concentration QSfg et aL, 1994). Both a- and p-MMC were not inhibitory 
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to mouse liver cells at concentrations higher than micromolar level (Chan et al., 
1992). 
On the other hand, MAP30 was also inhibitory to a variety of human 
tumour cell lines. The cell lines studied included the brain glioblastoma (87GM), 
breast carcinoma (BT20), epidemoid carcinoma (A431), liver hepatoma OHep 3B), 
melanoma 0VMme-3M), myeloma 0^266), neuroblastoma (SK-N-SH) and 
prostate carcinoma 0DU145) (Lee-Huang et aL, 1995b). The inhibitory activtiy of 
MAP30 on different cell lines was shown to be at nanomolar level. There is no 
report of anti-tumour activity for y-MMC. 
Table 1.9. Inhibitory activities ofa-MMC, p-MMC and MAP30 on different 
tumour cell Unes O^ee-Huang et aL, 1995b; Ng et aL, 1992). Inhibitory effects 
on cellular protein synthesis were measured.  
Tumourcelll ines~ |IC5oofDrugs(^M)*  
[ct-MMC |3-MMC MAP30 
. . 赵 ] ] ^ 9 扭 ? 1 运 函 = = = = : : = ] 互 : 「 r . 6 6 … … … : … … … 亜 • • • • H ] m ^ s g i ^ .."5793 0.86 ND  
】 胜 躲 ! 今 乡 9 £ | ^ 鹏 经 资 丄 亟 @ : 亟 : [ [ : : : o"il ..….••...ND*……… 
�?^??]1视..?.^^-9.4?.£汪—扭色说@1^^^^::: 0"28 0 . 2 6 . p i i '  �yEEL?k9^i9?J?—^?.!^^^i 0"02 0.03 S 5  
..M9]^.?.B®iE^9E.^.(?.IS 0"02 0.03 M i  
— 吞 赃 视 ^ ^ ^ ^ 鲍 £ 呢 ^ ^ 视 3 : 面 ! ^ ) 亜 i^5 0.00034… 
--lyEE[]iYE.ji^patOEa .....ND"...."..…0'm0S6.… 
••MyE??L^?!?^?-9.E!(M?ji^ ?:ii^  亜 而 0 00021… 
Human prostate carcinoma DU145) 而 而 0.00188… 
* ICso = 50 % inhibitiory concentration; ND = Not determined. 
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It is not known why a-MMC, P-MMC and MAP30 are selectively 
inhibitory to tumour cell lines. It was suggested that the mechanism may be 
common in embryonic tissue and tumor cells as both of them have common 
properties, e.g. rapid cell divisions and protein synthesis (Chan et al., 1992). 
(v) anti-viral activity 
The most striking activity of the Rffs from M. charantia is their anti-
human immunodeficiency virus (anti-KDV) activities. a-MMC, P-MMC and 
MAP30 have anti-fflV activity ¢ ^ et al” 1992; Lee-Huang et al, 1990). 
Take MAP30 as an example. MAP30 inhibited HTV in vitro. It showed an 
IC50 of inhibition on HTV infection-induced cell fusion (syncytium formation) in 
HIV-infected H9 cells at concentration lower than nanomolar level (Table 1.10). 
It also inhibited expression of the HTV antigen p24 and the activity offflV reverse 
transcriptase in the infected cells with similar values ofIC50 (Table 1.10). While 
HTV in H9 cells was inhibited, MAP30 was non-toxic to the H9 cells. It showed 
an IC50 ofinhibition on protein synthesis in H9 cells at concentrations greater than 
3 nM. 
Table 1.10. Inhibitory effect ofMAP30 on fflV O^ee-Huang et al” 1995b). 
Assays 丨 Syncytium | p24 丨 RT | Cellular protein 
j formation | j | synthesis  
IC50 (nM) of the | 0.22 0.22 1 0.33 j >3000 
MAP30 in different 丨 
assays | | i j  
IC50 = 50 % inhibitory concentration. 
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It was suggested that the mechanism of the anti-HTV activity of RPs like 
MAP30 was not similar to that of the abortifacient, immunomodulatory or anti-
tumour activities fBarbieri et al” 1993)，i.e. the anti-HTV RJDPs do not exert their 
effect through inhibition of macromolecules. One possible mechanism was the 
topoisomerase activity of MAP30. As mentioned above, a-MMC, P-MMC and 
MAP30 were shown to be able to cleave circular viral DNA into a linear form. 
MAP30 was also confirmed to have such effect on fflV DNA 0-ee-Huang et aL, 
1995a). Meanwhile, MAP30 was able to interrupt UTV integrase, preventing the 
integration of HTV DNA into the DNA from normal cells (Lee-Huang et al., 
1995b). The topological inactivation and integration disruption were suggested to 
be the mechanisms for the anti-HTV activity ofMAP30 (Lee-Huang et al., 1995a). 
Nevertheless, the exact mechanism is still unknown and it requires further studies. 
Apart from inhibiting fflV, MAP30 is also inhibitory to herpes simplex 
virus OHSV). It inhibits both the HSV-1 and HSV-2 with values of IC50 lower 
than 1 nM in vitro in a lung fibroblast cell line (WI-38) ^Bourinbaiar and Lee-
Huang, 1996). The inhibition ofHSV may help cure AEDS patients with resistant 
strain ofHSV (Bourinbaiar and Lee-Huang, 1996). However, as the case of anti-
HTV activity, the mechanism for the anti-HSV activity remains to be defined. 
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(vi) immunotoxins 
Momordin is another name for a-MMC (Barbieri et aL, 1993). a-MMC 
was used to construct many immunotoxins (ITs) under the name of momordin 
OBattelli et al, 1996; Terenzi et al” 1996; Wawrzynczak et al.，1990; Dinota et al., 
1989; Stirpe et al., 1988). Momordin has been used to construct JJ for use as anti-
tumour agents. Many different types of momordin-containing ITs were made. 
Some of the tumours studied were bladder carcinoma (Battelli et al., 1996)， 
Hodgkin's disease (Terenzi et al., 1996)，lymphoma (Stirpe et al., 1988) and 
myeloma (Dinota et al” 1989). All these studies were in vitro. 
The production of ITs enabled the targeting of momordin to tumour cells 
with minimal non-specific cytotoxic effects OBarbieri et aL, 1993). Conjugating 
momordin to ITs also enhanced the cellular entry. The values of IC50 for the 
effect of momordin-based ITs on protein synthesis in tumour cell lines are at 
nanomolar concentrations or below ^)inota et al., 1989; Stirpe et al., 1988; 
Terenzi et al., 1996; Wawrzynczak et al.’ 1990) while the values of IC50 for the 
effect of momordin alone are at micromolar concentrations (Table 1.9). 
However, in spite of the effectiveness of the momordin-based ITs in vitro, 
many problems still exist in vivo. For example, there is the problem of hepatic 
clearance (Wawrzynczak et al., 1990). Glycosylation of the RJP may lead to the 
binding of the ITs to hepatic cells with consequent removal from blood stream. 
Meanwhile, repeated administration of IT into patients will result in immune 
response against the toxin (Battelli et al., 1996). 
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Switching to different ITs containing different Rffs can prevent the 
induction of immune response (Battelli et al., 1996). P-MMC and MAP30 are 
possible constituents for a-MMC. Meanwhile, new REPs can also be alternatives 
for making new ITs. Li fact, the present study was also prompted by the objective 
to search for new RDPs to prepare new ITs for different therapeutic strategies. 
1.3 Objective ofthis study 
The objective of this study was to isolate new RJPs from M. charanta. Li 
the therapy using ITs, repeated and prolonged injections would result in immune 
response against the IT OBattelli et al., 1996). It is because the protein nature of 
REPs and antibodies in the ITs induced the immune system. To circumvent this 
problem, switching to new TTs with different REPs after prolonged treatment is 
required ^attelli et al； 1996). 
Although four Rffs (a-, P-, y-MMC and MAP30) have akeady been 
identified and isolated from M charantia, more RIPs may exist in the plant. Li 
fact, during the cloning ofMAP30 gene, it was found that there were at least eight 
homologous genes related to MAP30 (Lee-Huang et aL, 1995a). Three of them 
were identified to be MAP30, a-MMC and p-MMC (Lee-Huang et cd., 1995a). 
The identity of the remaining isoforms were unknown. Thus, it is likely that more 
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RDPs can be isolated. These potential new Rffs may provide a new source for the 
production ofITs. 
Seeds and fruits were the target tissues for isolation of new RDPs in this 
study. They will be discussed separately in the following two chapters. 
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Chapter 2 
Study on a new ribosome-inactivating protein Of^ P) from 
Momordica charantia seeds 
2.1 Introduction 
Seeds usually have high concentrations of RCPs OBarbieri et al., 1993). 
Meanwhile, there may be more than one form o f R P in the seeds or other tissues 
of a plant. For example, in Saponaria officinalis L., there are four isoforais of 
RPs in its seeds, three in the roots and another three in the leaves fFerreras et al., 
1993). The existence ofmore than one form ofRBP in a tissue was also observed 
in the Cucurbitaceae plants. For example, in Trichosanthes kirilowii, there are 
trichosanthin and trichosanthes anti-fflV protein 29 (TAP 29) in the roots (Kubota 
et al” 1986; Lee-Huang et al., 1991; Toyokawa et aL, 1991). t i Luffa cylindrica, 
luffin-a and luffin-b exist in the seeds C^exmg et aL, 1991). 
]n M. charantia, there are four REPs, namely, a-MMC, p-MMC, MAP30, 
and y-MMC, ab:eady isolated from its seeds. But it is possible that some other 
new Rffs still exist. Li the cloning of MAP30 gene, homologous but different 
nucleotide sequences were identified (Lee-Huang et al., 1995a). It was suggested 
that there were at least eight related but distinct isoforms ofRBPs in M charantia 
fLee-Huang et aL, 1995a). Three ofthem were identified as a-MMC, p-MMC 
and MAP30 (Lee-Huang et al, 1995a). But the identity of the remaining 
sequences were unknown. This supports that new REPs may exist in the seeds of 
M. charantia. 
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In this chapter the isolation of a new RJDP from the seeds of M charantia is 
reported. To isolate the new RJDP from M. charantia seeds, the method for the 
isolation of a- and P-MMC was adopted (Go et aL, 1992). Li this method, affinity 
chromatography on Affi-Gel® blue gel was used fFig. 2.1). This affinity gel has 
triazine dye functional groups and it can adsorb nucleotide-dependent enzymes 
including RH>s ^Vlunoz et al., 1990). 
The salt-eluted proteins from the affinity column were loaded on a fast 
protein liquid chromatography OFPLC) column of Mono S after dialysis. Mono S 
is a cation-exchanger with fine matrix particles which allow high pressure and 
high speed chromatography with high efficiency. With the high resolution of the 
Mono S column, the salt-eluted proteins from the affinity column were resolved 
into individual peaks. 
To characterize the biological activities of the isolated proteins, assays for 




(i) Grind seeds in 1 OmM NaH2PO4, pH 7.0; 
(ii) Centrifuge to remove debris; 




Affinity chromatography on Affi-Gel blue gel 
^ / ^ 
Breakthrough Salt-eluted proteins 
(i) Concentrate by ultrafiltration; 
(ii) Dialyze against 2mM phosphate 
V buffer,pH 7.5. 
FPLC ion-exchange chromatography on Mono S 
N^  
NewREP 
Fig. 2.1 Procedure for the isolation of a new ribosome-inactivating 
protein (RIP) from Momordica charantia seeds. 
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2.2 Materials and Methods 
2.2.1 Materials 
Ripe dried seeds of Momordica charantia (bitter gourd) were purchased 
from the local market. The seeds were stored in a cool dry place before use. 
Before extraction, the seeds were decorticated. Affi-Gel® blue gel (100-200 mesh 
size), Mini-PROTEAN® E electrophoresis cell for the SDS-PAGE and agarose 
(high strength analytical grade) were products ofBio-Rad OJ.S.A.). The Mono S 
HR 5/5 FPLC column was purchased from Pharmacia LKB (Sweden). 
SPECTRATPOR® dialysis membranes were purchased from Spectrum O^.S.A.). 
Diethyl pyrocarbonate ODEPC), bromophenol blue, ethidium bromide, hemin, 
creatine kinase and creatine phosphate were purchased from Sigma (XJ.S.A.). 
Aniline and formamide were products of Merck & Co. O^.S.A.). Phenol and 
chloroform were purchased from USB (JJ.K.). The RNA marker was purchased 
from Promega O^.S.A.). Photographic fihn model 667 was purchased from 
Polaroid (U.S.A.). Tritiated leucine was purchased from Amersham ^U. K.). 
Rabbit reticulocyte lysate was obtained from rabbits raised at the University 
Animal House, the Chinese University of Hong Kong (C.U.H.K.). All other 
reagents were of analytical or molecular biology grade, tf possible, they were 
autoclaved. Precautions for RNA work were taken throughout the process. 
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2.2.2 RIP isolation 
Preparation of crude extract 
Li a typical extraction, 5 g of decorticated seeds were ground by pestle and 
mortar until they became powder form. The powder was than homogenized in 40 
ml of 10 mM NaH2PO4, pH 7.0 by Polytron (Kinematics). The slurry was stirred 
at 4°C for 3 hours. It was then centrifuged at 30,000 g for 1 hour at 4°C in a high-
speed centrifuge (Beckman model J2-MC). The pellet was discarded and the 
supernatant was filtered through cheesecloth. It was then dialyzed at 4°C 
overnight against 10 mM NaH2PO4, pH 7.0 in a dialysis tubing (SPECTRAyTRO 
®) of 3,500 molecular weight cut-off (MWCO) in a cold room. 
Affinity chromatography on Aff!-Gel blue gel 
Crude extract from the seeds was mixed well with Affi-Gel blue gel ( � 8 
ml) which was equilibrated with 10 mM NaH2PO4, pH 7.0. They were mixed 
well by shaking. It was then centrifuged at 3,800 g at 4°C for 5 minutes at a table-
top centrifuge QBeckman). The supernatant ( �3 5 ml) was collected as unadsorbed 
(breakthrough) proteins and stored at 4°C. The gel was then further washed in the 
buffer five more times with a total volume of 240 ml. The gel was then packed in 
an Econo colunm (BioRad) to form an Affi-Gel blue gel column (1 x 8.6 cm). 
The gel was washed with 72 ml buffer to further remove any unbound proteins. It 
was then eluted with 0.5 M NaCl in the same buffer. 
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The salt-eluted fractions ( �2 3 ml) were pooled and dialyzed against 2 mM 
NaH2PO4, pH 7.5 using a 3,500 MWCO dialysis tubing. It was concentrated 
through a 3,000 MWCO filter membrane in a concentrator (Amicon, U.S.A.). 
Chromatography on Mono S 
The concentrated sample ( �1 2 ml) was filtered through a 0.22 ^M filter. 
The adsorbed fraction from the Affi-Gel blue gel column was filtered and then 
applied to a Mono S HR 5/5 fast protein liquid chromatography OFPLC) column 
fPharmacia, Sweden) previously equilibrated with 2 mM NaH2PO4, pH 7.5. The 
Mono S column was connected to a Waters 600S/486 (U.S.A.) HPLC and UV 
monitor system, t i a typical run, 1 ml of the filtered sample was injected into a 1 
ml sample loop and loaded on the column at a flow rate of 1 mVmin. The 
breakthrough protein peak was collected. Afterward, another 1 ml sample was 
injected. The method included washing for 10 min. with buffer and a linear 
gradient of 0-60 mM NaCl in the buffer for 60 min. The eluted protein peaks 
were dialyzed against distilled water in a 10,000 MWCO dialysis tubing. 
2.2.3 Characterization 
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) 
Electrophoresis of protein samples was performed according to the 
procedure previously reported (Laemmli and Favre, 1973). The resolving gel was 
composed of 15 % (w/v) acrylamide, 0.375 M Tris, pH 8.8，0.1 % (w/v) SDS, 1 % 
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ammonium persulfate and 6.6 X 10_5 % TEMED. The stacking gel was composed 
of 5 % (w/v) acrylamide, 6.25 mM Tris, pH 6.8, 0.1 % (w/v) SDS, 1 % 
ammonium sulphate and 7 x 10'^  % TEMED. Analysate were diluted with a 
buffer which was composed of 1/4 v of stacking gel buffer, 20 % glycerol (w/v), 
10 % SDS (w/v), 0.005 % bromophenol blue, and lmM EDTA, pH 7.5. The 
diluted sample was boiled for 5 min. The electrophoresis buffer was composed of 
0.025 M Tris, pH 8.3, 0.192 M glycine and 0.1 % SDS (w/v). Electrophoresis was 
carried out at a constant current of 16 mA and room temperature for about 1.5 hr. 
The gel was stained with 0.115% Coomassie Brilliant Blue R-250 in a staining 
solution composed of 8% (v/v) acetic acid and 25 % (v/v) ethanol for 1 hr, and 
then destained in a solution of acetic acid: ethanol: water (1:3:4, v:v:v) until the 
background was clear. 
Amino acid sequence analysis 
Proteins for amino acid sequencing were first separated by SDS-PAGE 
using 15 % polyacrylamide gel as described above. The gel was rinsed with 
double-distilled water and soaked in transfer buffer (25mM Tris and 192 mM 
glycine，pH 8.3 with 15% methanol) for about 5 minutes. Four filter papers of 
about the same size as the gel were also soaked in the transfer buffer. Meanwhile, 
a polyvinylidene difluoride (PVDF) membrane, which was also about the size of 
the gel, was soaked in 100% methanol for a few seconds and then soaked in the 
transfer buffer for about 10 to 15 minutes. 
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The polyacrylamide gel was laid above the PVDF membrane and they 
were sandwiched between the buffer-soaked filter papers (2 above and 2 below 
them) in a blotting cassette (BioRad, U.S.A.). The blotting was carried out at a 
constant voltage of 22V for lhr. Afterward, the PVDF membrane was stained 
with 0.1% Coomassie Blue for 1 hr and destained ovemight. 
The desired protein band was cut out and rinsed thoroughly with double-
distilled water. It was then applied to an amino acid sequence analyser (Hewlett 
Packard, U.S.A., by courtesy ofDr. Wing-Shing Ho, the Chinese University of 
Hong Kong). 
Determination of protein concentration 
Protein concentration was determined by the method previously reported 
(Lowry et al., 1951) using bovine serum albumin (BSA) as a standard. To each 0.1 
ml sample, 1 ml solution A (1% CuSO4.5H2O : 2 % Na3C6H5O7.2H2O : 2 % 
Na2CO3 in O.lN NaOH, 1:1:100，v:v:v) was added. The sample was allowed to 
stand at room temperature for 10 min. Then 0.2 ml solution B (1 to 1 dilution of 
Folin's reagent in water) was added immediately followed by mixing. After 
standing at room temperature for another 45 min, absorbance at 750 nm was 
measured using a Hitachi U2000 spectrophotometer. 
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iV-glycosidase assay 
Sample 10 |il was added to a mixture composed of 70 ^1 rabbit 
reticulocyte lysate and 60 i^l buffer A (25 mM Tris-HCl, pH 7.6，25 mM KC1, 5 
mM MgCl2). The negative control was 10 |il DEPC-H2O instead of sample. The 
positive control was 10 ^1 trichosanthin (TCS, a type I Rff, final concentration, 
0.33 |jM). The reaction mixture was incubated in a dry bath OEppendorf) at 37°C 
for 30 min. The reaction was stopped by adding 260 ^1 0.77 % SDS and chilling 
in an ice-bath. 
RNA was extracted with phenol:chloroform equilibrated with 0.1 M Tris-
C1, pH 8.0. An equal volume of phenoVchlorofonn (equilibrated with 0.1 M Tris-
C1, pH 8.0) was added to the SDS-treated reaction mixture in an Eppendorf vial 
followed by gentle mixing until an emulsion was formed. The aqueous layer was 
separated by centrifugation in an Eppendorf centrifuge at 14,000 rpm, 4°C for 2 
min. The aqueous layer was re-extracted using the same procedure. 
RNA obtained from the phenoVchloroform extraction step was mixed with 
2 volumes of absolute ethanol and 0.1 volume of 3M sodium acetate, pH 5.2. The 
mixture was well vortexed and kept at -20°C for 30 min. It was centrifuged at 
14,000 rpm, 4°C for 25 min. in an Eppendorf centrifuge. The ethanol layer was 
decanted. The RNA pellet was washed with 70 % ethanol and centrifuged for 5 
min. The RNA pellet was resuspended in formamide. After washing, the 
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precipitated RNA was resuspended in 16 |il foraiamide. Half of the resuspended 
• V 
RNA was incubated with 10 volumes of 10 % (v/v) distilled aniline (working 
aniline) in a dry bath at 37°C for 3 min. The other half was labelled as untreated 
(-ve) RNA and stored at -70°C. 
Working aniline was prepared from distilled aniline, acetic acid and 
DEPC-H2O (60: 90: 444，v:v:v). Ten volumes of working aniline were mixed 
with the extracted RNA. The mixture was mixed well and incubated at 60°C for 3 
min. Afterward, the mixture was chilled on ice and then spun down for a few 
seconds. The aniline-treated RNA was then precipitated as described above. The 
RNA was resuspended in 8 jid formamide. 
The aniline-treated (+ve) and untreated (-ve) RNA were analysed by 
formamide gel electrophoresis. Formamide gel (1.2 %) was prepared. Agarose 
(0.48 g) was melted in 16 ml DEPC-H2O in a microwave oven. Then 4 ml of 
electrophoresis OEP) buffer (36 mM Tris, pH 7.6, 30 mM NaH2PO4, 2mM EDTA-
Na) and 20 ml of 100 % formamide were added. After mixing and cooling, the 
mixture was poured into a plastic gel cast. 
An aliquot of 3 ^1 precipitated RNA was mixed with 1 ^1 EP buffer, 6 i^l 
100 % formamide and 1 ^1 gel loading buffer (0.5M EDTA and 0.5 % (w/v) 
bromophenol blue in glycerol). The mixture was incubated in a dry bath at 65°C 
for 5 min. Afterward, the sample mixture was chilled on ice and spun down for a 
few seconds. 
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Before sample loading, the agarose gel was placed in a gel tank filled with 
electrode buffer (10 % EP buffer, 50 % foraiamide, 40% DEPC.H2O). Samples 
were then loaded. Electrophoresis was run at 80V for 1.5 hour. The gel was 
stained with ethidium bromide (0.5 [xg/ml) for 10 min. and then destained for 15 
min. in distilled water. The gel was photographed with polaroid 667 instant fihn. 
To prevent RNase contamination, gloves were wom throughout the whole 
process. Whenever possible, sterile disposable plasticware was used. Reusable 
plasticware was soaked in a 0.1 % (v/v) solution ofDEPC followed by rinsing in 
DEPC-treated distilled water prior to use. Glassware was heated at 180°C 
overnight. Water and buffer were stirred in 0.1 % (v/v) DEPC overnight at room 
temperature and then autoclaved before use. Tris buffer was non-autoclavable. It 
was prepared from the DEPC-treated water and autoclaved. Wherever possible, 
all other reagents were ofRNase-free quality. 
Cell-free translation inhibition assay R^EP assay) 
Rff assay was based on a previous method OPeUiam and Jackson, 1976) 
with modification. The sample was diluted with 0.1 mg/ml BSA. Ten microlitres 
ofthe diluted sample were mixed with 10 ^1 hot mixture (500 mM potassium 
chloride, 5 mM magnesium chloride, 130 mM phosphocreatine and 1 ^Ci L-[4,5-
3R]leucine) and 30ul of working lysate (0.1 i^M hemin; 5 |ig ofcreatine kinase in 
rabbit reticulocyte lysate). The reaction mixture was incubated at 37°C for 30 
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min. The reaction was stopped by addition of 330 |il lM NaOH containing 0.2% 
H2O2. The mixture was further incubated at 37°C for 10 min. 
The reaction mixture was divided into triplicates of 100 |il and pipetted 
into a 96-well plate (Nunc, U.S.A.). The reaction mixture was mixed with an 
equal volume of acidified caesin (40% (w/v) trichloroacetic acid and 2% (w/v) 
casein hydrolysate). It was kept in an ice-bath for 10 min. The precipitate was 
then collected by filtration on a circle of glass fibre filter paper (Whatman GF/A, 
U.K.) through a cell harvestor which was washed with absolute ethanol. 
The filter paper was suspended in scintillant (67% toluene, 33% Triton X-
100, 4 g/1 PPO and 0.4 g/1 POPOP) and counted in a liquid scintillation counter 
¢.56500 Beckman, U.S.A.). 
Preparation of rabbit reticulocyte lysate 
Rabbit reticulocyte lysate was used to provide rRNA for iV-glycosidase 
assay and cell-free translation apparatus for R P assay. Rabbits rendered anaemic 
by phenyUiydrazine was prepared as described previously (Maniatis, 1982). 
PhenyUiydrazine (1.2 %; neutralized to pH 7.5 with 1 M HEPES, pH 7.0) was 
injected subcutaneously into a 2-3 kg rabbit. Different volumes, 1.0, 1.6，1.2，1.6, 
and 2.0 ml, were injected on days 1，2，3, 4 and 5 respectively. The rabbit was 
bled on days 7 and 8. Blood was collected directly from the heart chamber with a 
heparin-rinsed syringe, mixed with normal saline containing 0.02% heparin, and 
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then centrifuged at 2,000g for 5 min. in a Beckman model J2-21 centrifuge. The 
packed cells were washed with normal saline three more times. The last 
centrifugation was carried out at 17,000 g for 30 min. The lysate thus formed was 
aliquoted and stored at -70°C with a stability for at least 6 months. 
2.3 Results 
Crude extract from the seeds of Momordica charantia was mixed with 
Affi-Gel blue gel. Afterward, unadsorbed proteins were washed off from the 
column and the gel was then packed into a column. The profile of elution from 
the column is presented in Fig. 2.2. Adsorbed proteins were eluted by 0.5 M NaCl 
as a single peak designated Affi_S (Affi_Seed extract) after it had been 
demonstrated that no ftoher unadsorbed proeins were eluted from the column by 
washing with 10 mM NaH2PO4 buffer, pH 7.0. 
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Fig 2.2 Profile of elution ofMomordica. charantia seed extract from Affi-Gel blue 
gel column (1x8.6 cm). Refer to section 2.2.2 for details. Briefly, crude extract 
from 5 g M charantia seeds was mixed with Affi-Gel blue gel equilibrated in lOmM 
NaH2PO4, pH 7.0. Unadsorbed (breakthrough) proteins were obtained by several 
times ofwashing. Afterward, the gel was loaded to the column and further washed 
with the buffer. The column was finally eluted with 0.5 M NaCl in buffer 
(indicated by the arrow). Fractions of 1 ml each were collected. The salt-eluted 
fractions (elution volume from 81 to 110 ml) were pooled to form Affi-S. 
After concentration and dialysis, AfFi-S was loaded to a Mono S column. 
The Affi-S was resolved by the Mono S column into ten peaks (Fig. 2.3). The 
first peak (peak 1) was the unbound (breakthrough) peak which was eluted before 
salt-elution began. The other nine peaks were eluted after salt elution begins. 
They were designated as peaks E to X with retention times of 13, 15, 24, 27, 41, 
43，53 and 63 min., respectively. 
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Fig. 2.3 Profile of elution ofAffi-S from a Mono S column. Refer 
to section 2.2.2 for details. Briefly, the column was washed with 
2mM NaH2PO4, pH 7.5 and eluted with a linear gradient of 0 - 60 
mM NaCl in the same buffer at a flow rate of 1 ml/min. Peaks I to 
X were collected. 
Among the peaks, peaks V, Vm and X were shown to have 7V-glycosidase 
activity (data not shown). By molecular weight determination and comparison of 
the results of a- and p-MMC isolation (Go et al,, 1992), peak Vm and peak X 
were identified as a- and p-MMC, respectively (data not shown). 
44 
1 2 3 4 M Molecular weight 
j^^^^i;^^^�jt^^^^^j^i^^^^^^^^^^^^^^^^^^^^^a^;:^^y^gi^^^^^g^j;^j^j^^^;>^;;^>^;^^j^j^|>.^^^>^^^^^gg^;>^y~^»^^^^;^y^^^^^^gjg *""* 
醒 觀 ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ® rkDa^  
^ ¾ ¾ ¾ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ * ^ ^ ¾ ^ ¾ ： \ x ^ a j ^^^^^^m^m^^^^^^^^^^m^^^^^^m^^m^m-^^^^^^^^^ *^^ ^^^^^ »^«»*#^ »^ •^ 8«^ ^^^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H i~ 94.0 
-::< •、： '、,/ ；•；- : . . . ； , " ^ ^ — 67.0 ^^^^^^m0M^^^^^^^^^^^^^^^^^^^mM^^Kw^^^^^^^^^^^m^m ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ B ^ ^ ^ ^ ^ ^ ^ B i ~ ^ ^ ^ ^ i i i ^ ^ ^ ^ ^ ^ ^ ^ H 43.0 
^ ^ ^ ; 鐘 _ _ 種 蒙 ! _ ^ ^ ^ ^ _ ^ ^ 寒 攀 | ( ^ ^ ^ ^ ^ ^ ^ _ _ | ^ ^ ^ ^ 8 ^ ^ ^ ® ^ ^ ^ ^ ® ^^^^^^H^^^^^^^^^^^^^^^^WI^^H 
^^^^^^^^?^^^響禱働^^^^^^^^__^^^^^^^耀藥爆黎^^^^^^^^^^攀^^穩尊|__1^^^ >^ di^ &tfito^  <^»£&»»«"胁1 - ftifni^wMr � ViMMP^  W9"*ww ，__哪, ^ ^ ^ ^ ^ ^ ^ ^ ^ t e ^ ^ ^ H M ^ M i * ^*"“^ 30.0 
,7^ '^ x?>V0'\,' '\' '?�j��2 ':^ :i^ t'' ���>(n��(��,/ 'r'i^^^0^''怎\斤'vS^^h'^ *^ ' ''' ^ 'V' ' ''^'^' XS >j"'^N^ v^ ^ t^ ^ ^^ ^^ _S^ iP^ ^^ P^^ ^^ ^^ S^ ^^ M^^ ^^ Si^ P^ W^ _^ ^^ Ki^ ^^ B 
|^ g^-,�"?V��\�"^ '^'V %^ '^^ :^^ i|^^  ~》<、公《^|V' V\/ C"'^^>^^  A^*^'  4's'^ ' '%- ； sV"/"'* ^ /^^^'>^i^'i%'&iMi S M ^ ^ ^ ^ M ^ ^ ^ ^ ^ ^ ^ ^ ^ H . _ P i * ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H 20.1 
!!^^^^^•糖翻|凝_逾徵1麵麵總纖徵翻鏺您鄉燃,^1_^^^_纖纖鬆^^5:|^錄丨麵_察_驗磁^^^^ 81¾^¾^¾¾^^^^^¾:!¾^¾¾!^^^^^¾¾¾¾¾^^^¾¾!^¾¾^¾^^^^^^^¾ i^ ^^ ^^ __IPI^ i^^ ^^ i_i"^ ;M_^ :^^ l^>^ ^^ ^^ ^^ l^^ i^^ ^^ ^^ ^^ _^ f^^ l^ Plfii"^ 3^ l^ l_^ _^ ^ ^ ^ P ^ ^ ^ M ^ ^ ^ ^ ^ ^ g ^ ^ ^ ^ B ^  
^ | 1 ? ^ 纖 : : 怨 羅 暖 》 赛 § $ 5 丨 緯 , 議 1 4 . 4 %^^^fc^^^®j^ t^^^^^ ½^'^/'" ^ ¾^ ^ ' ^1^¾ 
Fig. 2.4 SDS-PAGE of breakthrough peak and peak V (6-MMC) from Mono 
S column. Lane 1，trichosanthin (TCS, 2 i^g); lane 2，a-momorcharin (a-
MMC，2 ^g); lane 3，peakV(5-MMC) from Mono S column (1.5 i^g); lane 4， 
peak I (breakthrough) from Mono S column (0.5 i^g); lane M, protein 
marker (Pharmacia). a-MMC (29 kDa) and TCS (26 kDa) are standard 
proteins. 
Peak V was also analysed by electrophoresis. In Fig. 2.4, peak V and peak 
I (breakthrough peak) from the Mono S column were run in SDS-PAGE with the 
standard type I Rffs of a-MMC and TCS (Dr. T. B. Ng, Biochemistry 
Department, Chinese University ofHong Kong). Peak V was shown to be a single 
protein. The molecular weight of this single protein was found to be higher than 
those ofboth a-MMC (29 kDa) and TCS (26 kDa). It was estimated to be about 
30 kDa. Peak I consisted of a number of different proteins but no 30 kDa protein 
as the peak V. 
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Fig. 2.5 A^-glycosidase activity of peak V (6-MMC) from Mono S. Assay 
method was described in section 2.2.3. Sixty nanogram ofrRNA from rabbit 
reticulocyte lysate was loaded to each sample lane. Lanes 1 & 2: negative 
control of DEPC-H2O; lanes 3 & 4: positive control of trichosanthin (TCS, 
0.33 i^M); lanes 5 & 6，7 & 8，9 & 10，11 & 12: peak V from Mono S column 
(2.38 nM, 2.38 x 10'^ nM, 2.38 x 10"^  nM and 2.38 x 10"^ nM, respectively). 
The "+"，，sign indicates aniline treatment while "-" sign indicates no aniline 
treatment. 
Fig. 2.5 shows the iV-glycosidase activity of peak V. When rRNA from 
rabbit reticulocyte was treated with peak V at concentrations from 2.38 nM to 2.38 
X 10'3 nM, followed by aniline treatment, the characteristic Endo's band ofabout 
400 bases was observed. The positive control of the type I REP, TCS, also 
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produced the Endo's band when aniline-treatment was done. For both peak V and 
TCS, no Endo's band was seen when there was no aniline treatment ("-"’，lanes). 
There was also no Endo's band in the negative controls. 
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Fig. 2.6 Inhibitory effect of peak V (5-MMC) from Mono S column on cell-
free translation. Please refer to section 2.2.3 for details of the assay. 1 |iCi of 
tritiated leucine was added to each reaction tube. Data represent mean 土 
standard deviation (N=3). 
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The inhibitory effect of peak V on the cell-free translation inhibition was 
also determined and shown in Fig. 2.6. The 50 % inhibitory concentration (IC50) 
was estimated to be 0.15 nM. 
The first seven amino acids at the iV-terminal of the peak V protein were 
shown to be DVNFGLA in an amino acid sequence analysis. This sequence is not 
identical to the iV-teraiinal sequences of the previously isolated M charantia RJDPs. 
The yields of the proteins at different steps of isolation and purification of 
Rff from M. charantia seeds are presented in Table 2.1. From 5 g ofseeds, 34 ^g 
of peak V proteins were isolated. It represented 0.01 % ofthe crude extract. 
Table 2.1 Protein yields at different stages of isolation and purification of RIP 
from five grams of Momordica charantia seeds.  
Purification stage 1 Amount ofProtein I Protein yield (%) 
Crude extract 230.0 mg 100 
Affi-S 36.9 mg 16.1 
Mono S peak V (5-MMC) I 34 呢 j ^  
2.4 Discussion 
In the attempt to isolate new RJPs from the seeds of Momordica charantia. 
Peak V from the Mono S column was isolated. This peak V shows the 
characteristics of type I Rffs. Firstly, it is a single protein as shown in SDS-
PAGE (Fig. 2.4). Type H and JM RCPs have two or more subunits linked by 
disulphide bond and non-covalent interactions, tfpeak V is either ofthem, two or 
more proteins might have been seen in the SDS-PAGE. Meanwhile, as proteins in 
SDS-PAGE were run under denaturing conditions (with SDS and p_ 
mercaptoethanol), it is unlikely that undissociated subunits exist in the single 
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protein of peak V. Thus, it is also unlikely that peak V is type E or TV REPs. 
Secondly, the molecular weight of the peak V protein is about 30 kDa (Fig. 2.4). 
This is consistent with the molecular weights of other type I RPs. The N-
glycosidase activity OFig. 2.5) of the peak V protein confirmed that it is a RJCP. 
Li repeated isolation of peak V from the seeds of M charantia, it was 
found that the retention time of peak V was the same at about 27 min. with a 
corresponding NaCl concentration of about 17 mM. It is different from the 
elution concentration of 35 and 53 mM NaCl reported for a- and P-MMC, 
respectively, in a similar isolation procedure (Go et al., 1992). Jn fact, from the 
result of SDS-PAGE (Fig. 2.4), it was confirmed that the peak V protein 
possessed a molecular weight higher than that of a-MMC. And, since P-MMC 
(28 kDa) is lighter than a-MMC (29 kDa), the peak V protein is unlikely to be 
either a- or P-MMC. It is unlikely to be y-MMC (11.5 kDa) either. 
Since the peak V protein is similar in molecular weight to MAP30, a N-
terminal amino acid sequencing was carried out to investigate whether the peak V 
protein is MAP30. It was found that one out of the first seven A^-teraiinal amino 
acids was different between the peak V protein and MAP30. It is glycine at the 
fifth position of the peak V protein instead of asparatate in MAP30. Thus, the 
peak V protein is also not MAP30. 
As the peak V protein is not a-MMC, P-MMC, y-MMC or MAP30 but it 
showed iV-glycosidase activity as other RTPs，it is considered as a new Rff and 
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designated as 5-momorcharin (5-MMC) after the previously isolated 
momorcharins. 5-MMC is a type I R P isolated from the seeds of M. charantia. 
Like other RBPs, 5-MMC inhibited cell-free translation at a concentration 
as low as nanomolar level. From Fig. 2.6, it was found that the 50 % inhibitory 
concentration (IC50) of 5-MMC was 0.15 nM. Its effect was as high as a-MMC 
(IC50 = 0.12 nM) and p-MMC ^Cso = 0.11) (Yeung et aL, 1988). Nearly 90 % 
inhibition occured at a concentration of 1 nM. This showed that 5-MMC is as 
potent as other M. charantia seed Rffs. 
The yield of5-MMC was low (Table 2.1). Similarly, Rffs with low yields 
have been encountered in the isolation of a family of RDPs of saporins from 
Saponaria officinalis OFerreras et al., 1993). Jn a similar isolation procedure, 6.1 
and 3.4 mg of a- and P-MMCs were isolated, respectively OFong et al., 1996). 
The yield of 5-MMC was 100 folds lower than oc- and p-MMC. Similar wide 
I 
differences in the yield of Rffs from the same tissue was also observed in the 
Saponaria officinalis (Ferreras et al., 1993). The yield of the four different 
saporins from the seeds varied from 20.7mg/5 g seeds to 0.75 mgy^ 5 g seeds. As 
will be discussed in the general discussion, this may be due to a tissue-specific 
expression. Li some other parts of the plant, the yield of 6-MMC may be higher. 
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Chapter 3 
Study on a new ribosome-mactivating protein ^RIP) from 
Momordica charantia fruits 
3.1 Introduction 
The fruit of Momordica charantia has been a traditional Chinese medicinal 
plant since ancient time. Despite the intensive studies of RPs from the seeds of 
M. charantia, there are few studies ofRffs from its fruits. 
Li an investigation of the hypoglycemic action of M. charantia fruit 
extract, it was observed that the extract induced uterine bleeding (Sharma et aL, 
1960). This suggested that the fruit might have some abortifacient components. 
Two abortifacient proteins (a- and P-MMCs) from M. charantia were confirmed 
to be RJPs O^eung et al； 1988). But they were isolated from the seeds, not from 
the fruits. 
At present, one RJP was isolated from the fruits of M. charantia. It is the 
MAP30. This RDP exists in both the seeds and fruits of the plant ^.ee-Huang et 
cd； 1990). 
MAP30 may not be the only RJP in the fruit of M charantia. It was 
claimed that there may be more RJDPs in M. charantia 0-ee-Huang et aL, 1995a). 
A new Rff was purified from the fruits of M. charantia in the present 
investigation. 
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A method similar to that for the seeds was adopted with minor changes 
(Fig. 3.1). The seeds and the pulp were first removed. The fruit extract was then 
subjected to the precipitation by OMH4)2SO4. The proteins from the precipitate 
formed by addition of 30 % to 90 % saturated O^)2SO4 were applied to an Affi-
Gel blue gel affinity column. The adsorbed proteins were eluted by 0.5 M NaCl. 
After dialysis, these proteins were resolved by FPLC on the cation-exchange 
Mono S column. 
Fruit with seeds and pulp removed 
(i) Extract with 1 OmM NaH2PO4 buffer, pH 7.0; 
(ii) Precipitation by 30 % to 90 % saturated OSnftO2SO4inbuffer. N^  
Crude extract 
vi' 
Affinity chromatography on Affi-Gel blue gel 
人 
Breakthrough Salt-eluted proteins 
(i) Concentrate by ultrafiltration; 
(ii) Dialyze against 2mM phosphate buffer, 、， pH7.5. 
FPLC ion-exchange chromatography on Mono S 
\y 
NewRTP 
Fig. 3.1 Procedure for the isolation of a new ribosome-inactivating 
protein fRBP) from the fruits ofMomordica charantia fruits. 
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3.2 Materials and methods 
3.2.1 Materials 
Fresh unripe fruits of Momordica charantia (bitter gourd) were purchased 
from a local market. They were stored at -20°C before use. Before extraction, the 
fruits had their seeds and pulp removed. Affi-Gel® blue gel (100-200 mesh size), 
Mini-PROTEAN® n electrophoresis cell for SDS-PAGE and agarose (high 
strength analytical grade) were products of Bio-Rad O^.S.A.). Mono S HR 5/5 
FPLC column was purchased from Pharmacia LKB (Sweden). SPECTRAyTOR® 
dialysis membranes were purchased from Spectrum (U.S.A.). Ammonium 
sulphate, diethyl pyrocarbonate QDEPC), bromophenol blue, ethidium bromide, 
hemin, creatine kinase and creatine phosphate were purchased from Sigma 
OJ.S.A.). Aniline and formamide were products of Merck & Co. (U.S.A.). 
Phenol and chloroform were purchased from USB OU.K.). The RNA marker was 
purchased from Gibco O^.S.A.). Photographic film model 667 was purchased 
from Polaroid O^J.S.A.). Tritiated leucine was purchased from Amersham 0^. K.). 
Rabbit reticulocyte lysate was obtained from rabbits raised at the University 
Animal House, the Chinese University of Hong Kong (C.U.H.K.). All other 
reagents were of analytical or molecular biology grade. Jf possible, they were 
autoclaved. Precautions for RNA work were taken throughout the process. 
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3.2.2 RIP isolation 
Preparation of crude extract 
Li a typical isolation, 500 g of unripe and deseeded fruits were blended in 
two volumes of 10 mM NaH2PO4, pH 7.0. After 1 hr., the extract was filtered 
through cheese cloth. It was then centrifuged at 9,500 rpm for 30 min. in a high 
speed centrifuge OBeckmann, J2MC) at 4°C. The supernatant was retained. 
Ammonium sulphate was then added to the supernatant to make a 30 % saturated 
solution. After stirring for 30 min. at 4°C, the solution was centrifuged at 9,500 
rpm again at 4°C for 15 min. The supernatant was collected and ammonium 
sulphate was added to reach a final saturation of 90 %. It was stirred at 4°C for 30 
min. and again centrifuged at 9,500 rpm and 4°C for 15 min. The precipitate was 
resuspended in 5 ml buffer. It was dialyzed against the buffer using a dialysis 
tubing with a molecular weight cut-off (MWCO) of3,500. 
Affinity chromatography on Affi-Gel blue gel 
The dialyzed sample was loaded on an Affi-Gel blue gel column (1 x 7.2 
cm), which had been equilibrated with 10 mM NaH2PO4, pH 7.0. The column 
was eluted with the same buffer at a flow rate of 1 nJAnin. After all the unbound 
proteins had been washed off (-25 ml), the column was eluted with 0.5 M NaCl in 
the buffer at 1 mVmin. Fractions of 1 ml each were collected. The fractions 
corresponding to the eluted peak were pooled and dialyzed against 2 mM 
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NaH2PO4, pH 7.5 using a dialysis tubing with a MWCO of 3,500. The dialyzed 
sample was concentrated through a filter membrane with a MWCO of 10,000 in 
an Amicon concentrator. 
Chromatography on Mono S column 
The concentrated sample ( �1 2 ml) was filtered through a 0.22 mM filter. 
The adsorbed fraction from the Affi-Gel blue gel column was filtered and then 
applied to a Mono S HR 5/5 fast protein liquid chromatography (FPLC) column 
(Pharmacia, Sweden) previously equilibrated with 2 mM NaH2PO4, pH 7.5. The 
Mono S column was connected to a Waters 600S/486 (U.S.A.) HPLC and UV 
monitor system, t i a typical run, 1 ml of the filtered sample was injected into a 1 
ml sample loop and loaded on the column at a flow rate of 1 nJAnin. The 
breakthrough protein peak was collected. Afterward, another 1 ml sample was 
injected. The method included washing for 10 min. with buffer and a linear 
gradient of 0-60 mM NaCl in the buffer for 60 min. The eluted protein peaks 
were dialyzed against distilled water in a dialysis tubing with a MWCO ofl0,000. 
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3.2.3 Characterization 
Characterization using SDS-PAGE, iV-glycosidase assay and cell-free 
translation inhibition fRP) assay was carried out as described under section 2.2.3 
in chapter 2. 
3.3 Results 
During affinity colunm chromatography on Affi-Gel blue gel, most of the 
unbound proteins in the crude extract were washed off the colunm after elution 
with 25 ml buffer (Fig. 3.2). When the column eluted with 0.5 M NaCl in the 
buffer, a smaller peak was eluted. It was designated as the peak Affi-F (Affi-fruit 
extract). 
The Affi-F was resolved on the Mono S column (Fig. 3.3) into two peaks. 
The breakthrough peak was designated peak A. Another peak was the salt-eluted 
peak and it was designated peak B. Peak B was eluted at about 23 min at a NaCl 
concentration of about 13 mM. 
Peaks A and B were analysed by SDS-PAGE (¥ig. 3.4). Peak A was not 
homogeneous. It consisted mainly of proteins with a molecular weights ranging 
from above 20.1 kDa to about 64 kDa. Two major bands between 30 and 43 kDa 
were observed. 
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Fig 3.2 Profile of elution of Momordica charantia fruit extract 
from Affi-Gel blue gel column (1 x 7.2 cm). Refer to section 
3.2.2 for details. Briefly, crude extract from 500 g M charantia 
fruits was loaded to the Affi-Gel blue gel column. After 
washing with 25 ml of 10 mM NaH2PO4, pH7.0, the column 
was eluted with 0.5 M NaCl in buffer (indicated by the arrow). 
Fractions of 1 ml each were collected. The salt-eluted fractions 
(elution volume from 30 to 45 ml) were pooled to form Aff!-F. 
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Fig. 3.3 Profile of elution ofAffi-F from Mono S column. Refer to section 3.2.2 
for details. Briefly, the column was washed with 2mM NaH2PO4, pH 7.5 and 
eluted with a linear gradient ofO _ 60 mM NaCl in the same buffer at a flow rate of 1 ml/mln. Peaks A and B were collected. 
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Fig. 3.4 SDS-PAGE of peaks A and peak B (e-MMC) eluted from Mono S. 
The gel was 15 % acrylamide gel. Lane M, protein marker (Pharmacia); 
lane 1，peak A (breakthrough) from Mono S column (0.5 i^g); lane 2，peak B 
from Mono S column (1.0 ^g); lane 3，a-momorcharin (a-MMC, 2 i^g); lane 
4，trichosanthin (TCS, 2 ^g). a-MMC (29 kDa) and TCS (26 kDa) are 
standard proteins. 
Peak B consisted of a single protein which was 24 kDa in molecular 
weight. This was confirmed by comparison with the patttems of a-MMC and 
trichosanthin (TCS) in SDS-PAGE. The latter two proteins were 29 kDa and 26 
kDa，respectively, in molecular weight. Peak B obviously had a lower molecular 
weight. 
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Fig. 3.5 shows the result of the iV-glycosidase assay. Li lane 2, the type I 
Rff trichosanthin (TCS) after aniline treatment released the characteristic Endo's 
band of about 400 bases from rRNA. No such band was observed for the lane 
without aniline treatment (lane 1). A similar result was observed for peak B (lanes 
4 and 3). The 28 S rRNA band in lanes 2 and 4 disappeared. No such 
disappearence ofband was observed in lanes 1 and 3 without aniline treatment. 
M 1 2 3 4 
RNA marker - + - + 
(kilobase,kb) ^ ^ ^ | | | | ^ ^ ^ ^ | | ^ ^ ^ ^ | 
4.40 ~ ~ ^ | ^ ^ ^ ^ H ^ ^ | ^ | ^ 28S 237 DtntH 
"^^Hi^ff" 
^ Endo's band 0.24 ~ ^ L n J H I H H H I I H H I 
Fig. 3.5 iV-glycosidase activity of peak B (s-MMC) from Mono S. 
Assay method was described in section 3.2.3. Sixty nanogram of 
rRNA from rabbit reticulocyte lysate was loaded to each sample 
lane. Lanes 1 & 2: positive control of trichosanthin (TCS, 0.33 
mM); lanes 3 & 4: peak B from Mono S column (0.4 ^M). Lane 
M, RNA marker (Gibco). The "+"，，sign indicates aniline 
treatment while "-" sign indicates no aniline treatment. 
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The cell-free translation-inhibitory activity of peak B was shown in Fig. 
3.6. The 50 % inhibitory concentration C^ C50) of peak B on the translation in 
rabbit reticulocyte lysate was 0.17 ^M (between 0.15 and 0.2 _ • 
75 "] 
g 6 5 - y f ^ " 
广 / 
^ 5 5 - / 
^ T / � 50 - / 
I 4 5 / 8 45 - y^ i 
53 T / 
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1 0 � 1Q1 1Q2 103 104 
Concentration of peak B (e-MMC) 
from Mono S column (nM) 
Fig. 3.6 Inhibitory effect of peak B from Mono S column on cell-
free translation. Please refer to section 3.2.3 for details ofthe assay. 
1 i^Ci of tritiated leucine was added to each reaction tube. Data 
represent mean 土 standard deviation (N=3). 
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The protein yields in the isolation and purification process are presented in 
Table 3.1. From 500 g deseeded fruits, 51.8 mg of crude extract was obtained. 
There were 3.2 mg protein adsorbed on the Affi-Gel column. About 94 % ofthe 
crude extract did not bind to the Affi-Gel colunm and were eluted as the 
breakthrough fraction. Peak B from the Mono S colunm contained 62 ^g material. 
More than 90 % of the Affi-F protein did not adsorb on Mono S. 
Table 3.1 Protein yields at different stages of purification o fRf f from five hundred grams of Momordica charantia fruits.  
Purification step | Amount ofProtein Protein yield (%) 
Crude extract 51.8 mg 100 
Affi-F I 3.2 mg 6.18 
Mono S peak B 62 i^g 0.12 
3.4 Discussion 
Fruits usually have only a little amount of proteins. This may explain why 
not many RDPs have been isolated from the fruits of a plant. Despite this, a new 
Rff has been isolated from the fruits of Momordica charantia in the present study. 
It was designated 8-momorcharin (s-MMC). 
i i the running of the Mono S column, only peaks A and peak B were 
obtained. The purity of the proteins from these two peaks was investigated by 
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SDS-PAGE. It was found that peak A was composed of several proteins while 
peak B consist of only a single protein. 
To investigate whether peak B is a RJDP，it was examined for A^-glycosidase 
activity. The molecular weight of the bands for peak B is similar to that of the 
known type I Rff, trichosanthin (TCS, Fig. 3.5). A characteristic Endo's band 
was observed for both proteins. The concomitant fainting of the 28 S rRNA band 
was due to cleavage of the rRNA and release of the Endo's band. For both 
proteins, there was no Endo's band in the non-aniline-treated "-" lanes. So, they 
were not RNases but specific iV-glycosidases. These results showed that peak B 
was a RCP and we designated it as s-momorcharin, s-MMC. 
s-MMC was not as potent as the other REPs. From Fig. 3.6, it was found 
that it had a 50 % inhibitory concentration (IC50) in the cell-free translation 
inhibition assay of 0.17 ^M. This is distinct from many other type I Rffs which 
had IC50 values in a similar assay ranging from 10 nM to 0.01 nM (Table 1.6). 
The significant deviation of the activity of s-MMC from other type I RPs may 
reflect some structural differences from others as will be discussed in chapter 4. 
The yield of s-MMC was not high. Only 62 ^g of s-MMC, was obtained 
from 500 g M. charantia fruits. The existence of a weak REP at a very low level in 
the fruit seems difficult to be explained. It seems ineffective for s-MMC to be 
functional at such a low level. The isolation of s-MMC may provide some clues 
about the physiological fimction of REPs in plants. 
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Chapter 4 
General Discussion and Conclusion 
4.1 General discussion 
The objective of this study was to isolate new RJDPs from Momordica 
charantia which could be utilized in the future for the production of new 
immunotoxins. As a result of the study, two new Rffs have been isolated from 
Momordica charantia. They were designated as 5-MMC and s-MMC 
respectively, after the previously isolated a-, P- and y-MMC. As discussed in the 
previous two chapters, these two MMCs were not the Rffs previously isolated 
from M. charantia. 
Differences between 5- and s-MMC 
The coincidence that the retention times for 5- and s-MMC in the Mono S 
colunm were similar (within the range from 23 min. to 27 min.) has prompted the 
question whether the two MMCs were actually the same protein. Jn repeated 
isolation of 5- and s-MMC, it was found that the retention times for both ofthem 
were still the same (at 27 and 23 min. for 5- and s-MMC, respectively). When 5-
and s-MMCs were subjected to SDS-PAGE, the difference became obvious. 
Their molecular weights were 30 kDa and 24 kDa, respectively (Fig. 2.5 and 3.4). 
In the investigation of the cell-free translation-inhibitory activity of these two 
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MMCs, a wide difference in activity was also observed OFig. 2.6 and 3.6). So, the 
two MMCs were actually distinct proteins. 
Relationship of 5- and s-MMC with other Momordica charantia REPs 
6- and s-MMC seemed to exist exclusively in the seeds and fruits, 
respectively. When M. charantia seeds extract was applied to Mono S column, 
three out of ten peaks were identified to be RPs. Two of them were a- and p_ 
MMC as isolated in a previous study (Go et al., 1992). The remaining one was 6-
MMC. A similar procedure was adopted for the isolation of fruit Rffs in M 
charantia. There was no peak for 5-MMC in the Mono S column elution profile 
when fruit extract was loaded (Fig. 3.3). On the other hand, the peak 
corresponding to s-MMC was also absent in the Mono S column elution profile 
for the seed extract (Fig. 2.3). 
The seemingly exclusive existence of 5- and s-MMC in the seeds and 
fruits, respectively, but not vice versa, may be due to differences in the gene 
product. Li a distribution study on saporins (type I REPs) from Saponaria 
officinalis, it was found that saporins from this plant could be categorized into 
leaf, root and seed Rffs (Terreras et al., 1993). Within the same tissue, isoforais 
of RJPs have similar amino acid compositions, iV-terminal amino acid sequences 
and even iV-glycosidase activities towards ribosomes. For example, the values of 
50 % inhibitory concentration (IC50) of saporin-S5 and saporin-S6 from seeds in a 
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cell-free translation inhibition assay (Rff assay) using the ribosome from rabbit 
reticulocyte lysate were 0.05 and 0.06 nM, respectively OFerreras et al” 1993). 
Those for saporin-Rl, saporin-R2 and saporin-R3 from the roots were 0.86, 0.47 
and 0.48 nM, respectively. Meanwhile, the IC50 of saporin-R3 from the roots in 
another RJP assay (using ribosomes from the plant of Vicia sativa) was 0.02 nM 
while that of saporin-L2 from the leaves was 20.91 nM ^'erreras et al., 1993). 
3 
The difference was 10 folds. These results led to the suggestion that the 
expression of saporins was tissue-specific and different saporins originated from 
different genes of the same family ^'erreras et al., 1993). This is supported by the 
fmding that saporin genes form a multigene family (Benatti et al., 1991). 
By the same token, 5- and s-MMC may also be the products of different 
genes and their expression may be tissue-specific. The most striking evidence was 
that there were large differences between the activities of these two new MMCs in 
the RH> assay (Fig. 2.6 and 3.6). The IC50 of5-MMC in this assay was 0.15 nM 
while that of s-MMC was 0.17 ^M. The difference was as large as 10^  folds. 
Yields of 5- and s-MMC 
The yields of 6- and s-MMC were quite low as well. From 1 g of seeds, 
6.8 jig of 6-MMC were obtained. It was 0.01 % ofthe crude protein extract (46 
mg，100 %) (Table 2.1). From 1 g of fruits, 0.12 i^g (0.1%) of s-MMC was 
obtained out of 103.66 昭(100%) crude extract (Table 3.1). Thier yields were 
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relatively low. Li a similar experiment for the isolation of a- and P-MMC, the 
yields were respectively 1.24 mg and 0.68 mg per gram of tissue (Fong et al., 
1996). This reflects the low abundance of 5- and s-MMC in the tissue. There 
were also low abundance of some REPs among others in a tissue. For example in 
Saponaria officinalis, there were at least seven RBPs (saporins) from different 
tissues. Li the seeds, there were four different saporins. Their yields varied from 
2.23 mg to 0.08 mg per gram of seeds. There was an approximately 30 folds 
difference. This difference may stem from the tissue-specific expression of 
different members of a multi-gene family as discussed above. The low yields o f5 
-and s-MMC may be due to expression of different genes. 
The expression of Rffs in the fruits seems to be a weak process. Apart 
from the low yield of s-MMC, the yield of a RJP from the fruits ofanother plant is 
also low. Pepocin is a type I Rff isolated from the fruits of Cucurbita pepo 
(Yoshinari et al., 1996). From 200 g of fruits from Cucurbita pepo, only 5.4 mg 
ofpepocin were isolated (27 ^g / g tissue). There is no data available on the seed 
RJDP in Cucurbita pepo. But, at least by comparing the yield of seed R P e.g. a-
and p-MMC from M, charanta (1.24 mg and 0.68 mg / g tissue, Fong et cd., 
1996)，it is shown that the yields for seed Rffs is much higher. This is consistent 
with the notion that the Rffs from different tissues are originated from different 
genes. This may also apply to Rffs in M. charantia. 
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Possible physiological function 
The low yield offruit Rffs in comparison with that of seed Rffs may have 
implications about the physiological function ofRffs . It was suggested that RPs 
may have metabolic function in the germination of seeds (Barbieri et aL, 1993). 
The relatively low yield ofs-MMC and the high yields of a- and P-MMC in seeds 
indirectly support this notion. But the exact role of RPs in seeds is still a 
mystery. Meanwhile, RIPs not only exist in seeds, they also exist in different parts 
of the plant, hi some cases, the activities of REPs in tissues other than seeds are 
even higher than those of seed RBPs (Barbieri et al., 1993; Ferreras et aL, 1993; 
Gasperi-Campani et al., 1985). The possible function in seed germination may 
not be the only function of RDPs. Further studies on the distribution of Rff will 
provide more information on the function ofRffs. 
On the other hand, the physiological fimction ofRffs may be related to the 
defense of plants (Stirpe and Barbieri, 1986). It was hypothesed that different 
Rffs may play different roles to defend the plant as an immune system ^"erreras et 
aL, 1993). There is no report about whether the concentration of RDPs will 
increase on encounter with pathogens. Further studies in this direction will throw 
more light on the physiological role ofRffs. 
t 
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Chromatographic behavior on Affi-Gel blue gel 
During the isolation process, MAP30 and y-MMC were not isolated. 
Among the ten peaks in the Mono S column elution profile, only the peaks 
corresponding to a-, P_ and 5-MMC ( peak X，VEI and V，respectively, in Fig. 
2.3) possessed iV-glycosidase activity. It was suspected that MAP30 and y-MMC 
might have co-eluted with other proteins unadsorbed on the Mono S colunm. But 
SDS-PAGE for the breakthough of Mono S column ^Fig. 2.4) indicated that there 
were no protein bands with a molecular weight of 30 kDa or 11.5 kDa 
(corresponding to the molecular weights of MAP30 and y-MMC, respectively). 
There was also no evidence for the existence ofMAP30 or y-MMC in the Mono S 
colunm breakthrough when the fruit extract was applied (Fig. 3.3). 
As the sample loaded onto the Mono S colunm was derived from the salt-
eluted fractions from the Affi-Gel blue gel column, MAP30 and y-MMC might 
have been eluted with the breakthrough proteins of that affinity colunm. to a 
study of the binding of RJPs to Affi-Gel blue gel, a correlation between 
glycosylation of RJP and binding onto this kind of affinity gel was observed 
OVIunoz et al., 1990). y-MMC is non-glycosylated (Pu et al., 1996). This property 
might have prevented it from binding to the Affi-Gel blue gel. 
Deglycosylation of ricin A-chain did not affect the binding of this subunit 
of type n Rff to bind to Affi-Gel blue gel (Munoz et al., 1990). Some other 
unknown properties might also prevent some Rffs from binding to the Affi-Gel 
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blue gel. This might explain why MAP30 was not detected in the salt-eluted 
fractions from the affinity column. 
Since the breakthrough proteins were mixed with different proteins like 
RNase，it was unable to identify any REPs inside the breakthrough fraction by the 
A^-glycosidase assay. All the 28S/18S RNA or Endo' s band was digested and 
appeared as a smear (data not shown). 
From the above discussion, it seems likely that, with the method used in 
this project, some unknown RIPs may have been missed just like MAP30 and y-
MMC. It was claimed that eight isoforais of genes o fRf f s were identified in M 
charantia leaves (Lee-Huang et al” 1995a). Three ofthem were claimed to be a-, 
P-MMC and MAP30. The identities of the remaining five isoforms were not 
available. The y-MMC isolated recently and the 5-MMC and s-MMC isolated in 
this project may be members of the eight isoforms. Jf it is true, there are at least 
two more RJPs which can be isolated from M. charantia. 
Possible use in the construction of immunotoxins 
The presence of more than one form of Rff in M charantia will help 
circumvent the problems which arise from the use of Rff-conjugated 
hnmunotoxins (ITs). Jn the therapies using Rff-conjugated ITs, immune 
responses against the YT will make prolonged treatment impossible. An effective 
solution is to switch to new RJPs after prolonged IT therapy (Battelli et aL, 1996). 
This would prevent immune responses against the Rff moiety. 
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New Rffs with low IC50 values will be useful. It is because a lower dose 
of ITs can produce an effect high enough to kill diseased cells in the body. This 
minimizes the risk of immune response against the IT. Table 4.1 shows that the 
IC50 of 6-MMC is one of the lowest among the REPs isolated from M. charantia. 
It is worthwhile to investigate whether this strong activity can be used to compact 
tumour, or other undesirable cells. 
The activity of s-MMC is quite low (IC50 at 0.17 ^M). However, since the 
values ofIC50 varies in different assay systems (Ferreras et aL, 1993)，it is possible 
that s-MMC may be very active in some other systems and effective in killing 
some types of cells. 
Table 4.1 The inhibitory activities ofREPs from Momordica charantia in cell-
free translation inhibition assay.  
M. charantia RIPs IC50 (nM) References  
a-MMC ^ O^eungetal., 1988) 
P-MMC 0.11 O^ eimg et aL, 1988) 
Y-MMC 55.00 (P« 过这1； 1996) 
MAP30 3.30 OLee-Huang et al.’ 1995a) 
5 - M M C 0.15 This thesis 
s-MMC l ]0 This thesis  
IC50： 50 % inhibitory concentration. 
In the future, experiments such as cytotoxicity studies using human cell 
lines should be done to characterize the effects of 5- and s-MMC and evaluate the 
feasibility for them to form ITs. 
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To sum up, the isolation of 6- and s-MMC has provided new possible 
conjugates for the production of immunotoxins. Meanwhile, they may also 
provide important information for the gene structure and so the evolution of RIPs 
in M charantia. They are also important for the study on the distribution o fRf f s 
in plants (at least in M charantia). 
4.2 Conclusion 
Momordica charantia contains several ribosome-inactivating proteins 
(RBPs). The previously isolated M. charantia REPs are a-momorcharin (a-MMC), 
P-momorcharin (P-MMC), y-momorcharin (y-MMC) and Momordica anti-HW 
protein 30 (MAP30). fc this project，two new RTPs，namely 5- and s-momorcharin 
(6- and s-MMC), have been isolated from the seeds and fruits of Momordica 
charantia, respectively. 
5-MMC is similar to other M. charantia RBPs in many aspects. It is a 
single-chain protein with a molecular weight of 30 kDa. It has A^-glycosidase and 
cell-free translation-inhibitory activities which are as strong as those of the other 
M. charantia RH s^ previously isolated. But the yield of 5-MMC is low. 
s-MMC is also a single-chain protein as 5-MMC. Its molecular weight is 
24 kDa. Despite these similarities with other M. charantia RTPs, the N-
glycosidase and cell-free translation-inhibitory activities of s-MMC are less active 
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than other M. charantia RH>s. Similar to 5-MMC, the yield of s-MMC is also 
low. 
The presence of more than one form of RPs provides alternatives for the 
production of different Rff-based immunotoxins containing different Rffs. This 
would prevent immune responses against the R P moieties in the immunotoxins. 
The exclusive existence of 5- and s-MMC in the fruits and seeds of M. 
charantia may indicate the presence of tissue specific expression of RBPs in M. 
charantia. Meanwhile, the presence of low yield RJPs (5- and s-MMC) among 
other RJPs and the expression of low activities of s-MMC in M charantia may 
provide some clues about the physiological role, such as germination and defense 
role, ofRJPs in M. charantia and other plants. 
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